Tati, Claribel .
HRN: 28-17-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2025
CEFUROXIME 1.5GM (VIAL)
12/19/2025
12/20/2025
IV
1.5gm
PTOR
Pre Op Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes